Versant Capital Management’s Kailera Therapeutics KLRA Stock Holding History

Versant Capital Management’s Portfolio KLRA Stock Details KLRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.5K	Buy	+1,186	New	+$20K	﹤0.01%	2149

Other funds holding KLRA

MCP

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Versant Capital Management's KLRA Position: Q3 2026 in Review

Versant Capital Management opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 1,186 shares worth $13.5K. The stake represents ﹤0.01% of the portfolio and ranks #2149 among its holdings.

4 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

Versant Capital Management held 1,186 shares of Kailera Therapeutics worth $13.5K as of Q3 2026.
Kailera Therapeutics was a new Versant Capital Management position in Q3 2026.
Kailera Therapeutics made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2149 holding.
4 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.